Advertisement

Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant, and Mood-Stabilizing Drugs

  • Alessandro SerrettiEmail author
  • Janusz K. Rybakowski
Chapter

Abstract

At the doctor’s office, after the first contact:

Keywords

Unwanted Side Effect Previous Chapter Buccal Swab Induce Weight Gain CYP2D6 Metabolizers 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Howland RH (2014) Pharmacogenetic testing in psychiatry: not (quite) ready for primetime. J Psychosoc Nurs Ment Health Serv 52(11):13–16. doi: 10.3928/02793695-20141021-09 CrossRefGoogle Scholar
  2. 2.
    Malhotra AK, Zhang JP, Lencz T (2012) Pharmacogenetics in psychiatry: translating research into clinical practice. Mol Psychiatry 17(8):760–769. doi: 10.1038/mp.2011.146 PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Olgiati P, Bajo E, Bigelli M, De Ronchi D, Serretti A (2012) Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries. Prog Neuropsychopharmacol Biol Psychiatry 36(1):147–154CrossRefPubMedGoogle Scholar
  4. 4.
    Winner JG, Carhart JM, Altar CA, Goldfarb S, Allen JD, Lavezzari G, Parsons KK, Marshak AG, Garavaglia S, Dechairo BM (2015) Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation. Curr Med Res Opin 31(9):1633–1643. doi: 10.1185/03007995.2015.1063483 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Biomedical and Neuromotor SciencesUniversity of BolognaBolognaItaly
  2. 2.Department of Adult PsychiatryPoznan University of Medical SciencesPoznanPoland

Personalised recommendations